To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Ozempic and other GLP-1 drugs like it have become so pervasive in the zeitgeist that it’s likely even your most social ...

Weight loss medications like Wegovy and Zepbound can be effective but may pose risks for older adults, including muscle loss and bone density decline.

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Weight-loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and potential health benefits. While the outcomes can be positive, Consumer Reports ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. | Novo Nordisk’s vision of 25%-plus weight ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.